The peptide's activation of ERK1/2 and downstream transcription factors including Egr-1 drives expression of collagen synthesis genes while its enhancement of cellular migration ensures efficient fibroblast recruitment to sites requiring matrix deposition, creating optimal conditions for rapid yet organized tissue reconstruction
Products are supplied solely for in-vitro research by qualified researchers
Research Administration and Dosing Considerations Published research on BPC-157 in animal models has used various administration routes: Intraperitoneal injection: Common in rodent studies but impractical for veterinary application Subcutaneous injection: More relevant to potential veterinary use Intramuscular injection: Studied in some larger animal models Oral administration: Some research suggests oral bioavailability, though data is limited Topical application: Investigated for wound healing applications Dosing in animal studies varies widely (typically reported as g/kg body weight), and optimal dosing for dogs specifically has not been established through controlled veterinary trials
The more recent STEP UP trial tested a higher dose of 7.2 mg and showed average weight loss of 20.7% at 72 weeks
Visual inspection Clear solution should remain clear: Any cloudiness = discard Particles floating = discard Color change = discard (especially important for copper peptides) Separation or layers = discard Exception: Some peptides may have slight natural color
When sterile water is used in peptide reconstitution: Almost never in routine multi-dose peptide use